Electronic Drug Delivery Systems Market Expected to Record Steady Growth and Approach $19.43 Billion by 2030
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Will Be The Estimated Market Valuation Of The Electronic Drug Delivery Systems Market By The End Of 2030?
The electronic drug delivery systems market has shown significant expansion in recent years. This market is set to expand from $11.93 billion in 2025 to $13.11 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.9%. The growth observed in the past can be ascribed to several factors, including the increasing occurrence of chronic diseases, the broader use of injectable and inhalable therapies, the rising adoption of infusion-based treatments, the expansion of home healthcare, and the wider accessibility of electronic drug delivery platforms.
The electronic drug delivery systems market size is anticipated to expand rapidly over the next few years. It is forecast to grow to $19.44 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 10.4%. This expansion during the projection period stems from factors such as the rising demand for personalized drug delivery, the increasing embrace of digital health ecosystems, the wider implementation of remote patient monitoring, a heightened focus on adherence-driven patient outcomes, and the growing integration of AI-based dosing algorithms. Significant trends anticipated for the forecast period encompass the increasing adoption of smart drug delivery devices, the rising integration of connected and wearable delivery systems, the expanding utilization of precision dose control technologies, the proliferation of patient-centric self-administration devices, and an enhanced emphasis on monitoring therapy adherence.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10734&type=smp
What Primary Drivers Are Shaping The Development Of The Electronic Drug Delivery Systems Market?
The increasing incidence of chronic illnesses is anticipated to fuel the expansion of the electronic drug delivery systems market in the future. A chronic disease is defined as an ailment or condition persisting over a year and necessitating continuous medical care. These electronic systems facilitate the regulation of medication dosages and simplify the monitoring of drug intake for individuals living with chronic conditions. As an illustration, data from January 2023, provided by the National Library of Medicine, a US-based entity, indicates that the population in the US aged 50 and older suffering from at least 1 chronic condition is projected to reach 142.66 million by 2050. Consequently, the growing occurrence of chronic diseases will stimulate the electronic delivery system market.
Which Segment Classifications Shape The Electronic Drug Delivery Systems Market?
The electronic drug delivery systems market covered in this report is segmented –
1) By Type: Electronic Infusion Pumps, Electronic Injection Pens, Electronic Auto-Injectors, Electronic Inhalers, Electronic Capsules
2) By Component: Sensors, Wireless Communicator And Antennas, Micro Pumps And Flow Regulators, Drug Reservoir, Microcontroller, Other Components
3) By System Type: Battery-Powered Systems, Rechargeable Systems
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies
5) By Application: Diabetes, Cardiovascular Disease, Respiratory Disorders, Multiple Sclerosis, Other Applications
Subsegments:
1) By Electronic Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps
2) By Electronic Injection Pens: Insulin Pens, Growth Hormone Pens, Other Injectable Medication Pens
3) By Electronic Auto-Injectors: Pre-filled Auto-Injectors, Spring-Loaded Auto-Injectors
4) By Electronic Inhalers: Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), Soft Mist Inhalers
5) By Electronic Capsules: Smart Capsules, Digital Capsules With Sensors
How Are Trends Impacting The Electronic Drug Delivery Systems Market?
Leading companies in the electronic drug delivery systems market are concentrating on innovative solutions, such as reusable electronic injector platforms, to improve drug delivery precision, patient adherence, and sustainability. A reusable electronic injector platform is a battery-powered, smart injection device that can be utilized multiple times to deliver precise doses of medication while tracking usage and supporting patient adherence. For example, in January 2025, Portal Instruments Inc., a US-based medical device company, unveiled PRIME Nexus, a new reusable electronic injector platform engineered to enhance the administration of injectable medications, offering specific advancements for precision, versatility, and sustainability in drug delivery. It accommodates multiple drug container sizes, including 1 mL and 2.25 mL pre-filled syringes and 3 mL cartridges, and can manage high-viscosity formulations up to 600 cP. The device features programmable injection control and optional connectivity for adherence monitoring and data sharing with healthcare providers. Its reusable nature promotes sustainability by reducing medical waste and lowering overall injection costs.
Which Companies Are Expanding Their Footprint In The Electronic Drug Delivery Systems Market?
Major companies operating in the electronic drug delivery systems market are Medtronic plc, Novo Nordisk A/S, Insulet Corporation, Tandem Diabetes Care Inc., United Therapeutics Corporation, Sanofi S.A., Abbott Laboratories, Roche Holding AG, Johnson & Johnson, Bayer AG, Antares Pharma Inc., CeQur Corporation, BIOCORP, Adherium Limited, Amiko Digital Health Limited, FindAir Sp. z o.o., HCmed Innovations Co. Ltd., Insulet International Limited, Ypsomed Holding AG, Enable Injections Inc., Eitan Medical Ltd.
Read the full electronic drug delivery systems market report here:
How Does The Electronic Drug Delivery Systems Market Perform Across Major Global Regions?
North America was the largest region in the electronic drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global electronic drug delivery systems market report during the forecast period. The regions covered in the electronic drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Electronic Drug Delivery Systems Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10734&type=smp
Browse Through More Reports Similar to the Global Electronic Drug Delivery Systems Market 2026, By The Business Research Company
Electroencephalography Eeg And Electromyography Emg Equipment Market Report 2026
Electro Medical And Electrotherapeutic Apparatus Market Report 2026
Electrocardiography Ecg Electrodes Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
